FDA panel narrowly backs Merck’s at-home COVID-19 pill

This content originally appeared on Reuters and was authored by Reuters

Print Share Comment Cite Upload Translate Updates

APA

Reuters | Sciencx (2021-12-01T10:35:23+00:00) FDA panel narrowly backs Merck’s at-home COVID-19 pill. Retrieved from https://www.scien.cx/2021/12/01/fda-panel-narrowly-backs-mercks-at-home-covid-19-pill/

MLA

" » FDA panel narrowly backs Merck’s at-home COVID-19 pill." Reuters | Sciencx - Wednesday December 1, 2021, https://www.scien.cx/2021/12/01/fda-panel-narrowly-backs-mercks-at-home-covid-19-pill/

HARVARD

Reuters | Sciencx Wednesday December 1, 2021 » FDA panel narrowly backs Merck’s at-home COVID-19 pill., viewed ,<https://www.scien.cx/2021/12/01/fda-panel-narrowly-backs-mercks-at-home-covid-19-pill/>

VANCOUVER

Reuters | Sciencx - » FDA panel narrowly backs Merck’s at-home COVID-19 pill. [Internet]. [Accessed ]. Available from: https://www.scien.cx/2021/12/01/fda-panel-narrowly-backs-mercks-at-home-covid-19-pill/

CHICAGO

" » FDA panel narrowly backs Merck’s at-home COVID-19 pill." Reuters | Sciencx - Accessed . https://www.scien.cx/2021/12/01/fda-panel-narrowly-backs-mercks-at-home-covid-19-pill/

IEEE

" » FDA panel narrowly backs Merck’s at-home COVID-19 pill." Reuters | Sciencx [Online]. Available: https://www.scien.cx/2021/12/01/fda-panel-narrowly-backs-mercks-at-home-covid-19-pill/. [Accessed: ]

rf:citation

» FDA panel narrowly backs Merck’s at-home COVID-19 pill | Reuters | Sciencx | https://www.scien.cx/2021/12/01/fda-panel-narrowly-backs-mercks-at-home-covid-19-pill/ |

Please log in to upload a file.

There are no updates yet.
Click the Upload button above to add an update.

You must be logged in to translate posts. Please log in or register.

Related Posts